Silicon Valley Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Buy
487
+3
+0.6% +$1.07K 0.02% 104
2025
Q4
$158K Buy
484
+4
+0.8% +$1.27K 0.01% 98
2025
Q3
$136K Buy
480
+4
+0.8% +$1.16K 0.01% 102
2025
Q2
$133K Sell
476
-81
-15% -$22.9K 0.01% 98
2025
Q1
$171K Buy
557
+4
+0.7% +$1.18K 0.02% 82
2024
Q4
$144K Buy
553
+5
+0.9% +$1.48K 0.02% 92
2024
Q3
$177K Buy
548
+3
+0.6% +$981 0.02% 80
2024
Q2
$170K Buy
545
+4
+0.7% +$1.18K 0.02% 79
2024
Q1
$154K Buy
541
+5
+0.9% +$1.46K 0.02% 72
2023
Q4
$154K Buy
536
+4
+0.8% +$1.09K 0.03% 72
2023
Q3
$143K Buy
532
+4
+0.8% +$998 0.03% 75
2023
Q2
$117K Buy
528
+85
+19% +$19.7K 0.02% 80
2023
Q1
$107K Buy
443
+4
+0.9% +$982 0.02% 82
2022
Q4
$115K Buy
+439
New +$118K 0.03% 82

Other funds holding AMGN

Silicon Valley Capital Partners's AMGN Position: Q1 2026 in Review

Silicon Valley Capital Partners increased its Amgen (AMGN) stake by 0.62% in Q1 2026, buying an estimated $1.07K and bringing the position to 487 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #104.

Silicon Valley Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $177K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Silicon Valley Capital Partners held 487 shares of Amgen worth $171K as of Q1 2026.
  • Silicon Valley Capital Partners bought 3 Amgen shares in Q1 2026, an estimated $1.07K.
  • Amgen made up 0.02% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #104 holding.
  • Silicon Valley Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Silicon Valley Capital Partners's Amgen position peaked at $177K in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.